Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001035704-04-000104
Filing Date
2004-03-03
Accepted
2004-03-03 16:50:43
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d13148e10vk.htm 10-K 1195558
3 CONSENT OF DELOITTE & TOUCHE LLP d13148exv23.txt EX-23 662
4 RULE 13A-14(A) CERTIFICATION OF THE CEO d13148exv31w1.txt EX-31.1 3524
5 RULE 13A-14(A) CERTIFICATION OF THE CFO d13148exv31w2.txt EX-31.2 3506
6 SECTION 1350 CERTIFICATION OF CEO d13148exv32w1.txt EX-32.1 1278
7 SECTION 1350 CERTIFICATION OF CFO d13148exv32w2.txt EX-32.2 1253
  Complete submission text file 0001035704-04-000104.txt   1208056
Mailing Address 2579 MIDPOINT DR FORT COLLINS CO 80525
Business Address 2579 MIDPOINT DR FORT COLLINS CO 80525 3034825868
ATRIX LABORATORIES INC (Filer) CIK: 0000809875 (see all company filings)

EIN.: 841043826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-18231 | Film No.: 04646564
SIC: 2834 Pharmaceutical Preparations